Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

China flag China · Delayed Price · Currency is CNY
7.32
-0.03 (-0.41%)
Mar 11, 2026, 3:04 PM CST
-45.90%
Market Cap 3.05B
Revenue (ttm) 216.15M
Net Income (ttm) -42.99M
Shares Out 414.69M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,598,500
Average Volume 5,462,735
Open 7.20
Previous Close 7.35
Day's Range 7.20 - 7.35
52-Week Range 6.32 - 13.85
Beta 0.47
RSI 46.23
Earnings Date Apr 29, 2026

About SHE:002693

Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Haikou, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 605
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002693
Full Company Profile

Financial Performance

In 2024, SHE:002693's revenue was 174.21 million, a decrease of -26.16% compared to the previous year's 235.93 million. Losses were -78.30 million, 54.3% more than in 2023.

Financial Statements

News

There is no news available yet.